Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) just unveiled an announcement.
China Shineway Pharmaceutical Group Limited has announced a second interim cash dividend of RMB 0.11 per share for the fiscal year ending December 31, 2025, which will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.09. The ex-dividend date is set for September 9, 2025, with the payment date scheduled for September 26, 2025. This announcement reflects the company’s financial strategy and commitment to providing returns to its shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:2877) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on China Shineway Pharmaceutical Group Limited stock, see the HK:2877 Stock Forecast page.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese medicine products. The company is known for its range of herbal medicines and health supplements, catering primarily to the Chinese market.
Average Trading Volume: 1,094,158
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$6.37B
For an in-depth examination of 2877 stock, go to TipRanks’ Overview page.